Latest Breaking News On - Nautilus biotechnology inc - Page 1 : comparemela.com

Vanguard Capital Wealth Advisors decreased its stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 13.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 6,000 shares during the period. Vanguard Capital […]

Sujalm patelPresidio capital managementExchange commissionSecurities exchange commissionKestra private wealth servicesChina universal asset management coNautilus biotechnology company profileSg americas securitiesHermes incNautilus biotechnology incVanguard capital wealth advisorsNautilus biotechnologyFree reportCapital wealth advisorCapital managementPrivate wealth services